CIAM
LXRX icon

Caitong International Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Caitong International Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551 Buy
353
+206
+140% +$300 ﹤0.01% 1616
2025
Q4 		$169 Sell
147
-812
-85% -$1.11K ﹤0.01% 1635
2025
Q3 		$1.29K Buy
+959
New +$1.09K ﹤0.01% 1431

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Caitong International Asset Management's LXRX Position: Q1 2026 in Review

Caitong International Asset Management increased its Lexicon Pharmaceuticals (LXRX) stake by 140% in Q1 2026, buying an estimated $300 and bringing the position to 353 shares worth $551. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Caitong International Asset Management first reported a position in LXRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.29K in Q3 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Caitong International Asset Management held 353 shares of Lexicon Pharmaceuticals worth $551 as of Q1 2026.
  • Caitong International Asset Management bought 206 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $300.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1616 holding.
  • Caitong International Asset Management first reported a position in Lexicon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's Lexicon Pharmaceuticals position peaked at $1.29K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.